Levetiracetam Tillomed (Levetiracetam)

Levetiracetam exerts its effect by binding to the synaptic vesicle protein SV2A, which plays a crucial role in neurotransmitter release. This binding modulates vesicle exocytosis, leading to a reduction in neuronal hyper‑excitability and the suppression of abnormal electrical discharges that cause seizures.

The dosage of Levetiracetam Tillomed is individualized by the prescribing clinician based on the patient’s age, renal function, seizure type, and response to therapy. The prescriber determines the starting dose and any subsequent titration to achieve optimal seizure control while minimizing adverse effects.

Safety data for levetiracetam in pregnancy and lactation are limited, and the product does not have a definitive pregnancy category. Healthcare providers should weigh the potential benefits against possible risks and discuss these considerations with the patient before initiating therapy.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with older agents such as carbamazepine or valproate, levetiracetam has a simpler pharmacokinetic profile, fewer drug‑enzyme interactions, and a generally favorable tolerability profile. However, individual response varies, and clinicians may choose alternative agents based on specific seizure types, comorbidities, and patient preferences.

Levetiracetam Tillomed should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Levetiracetam Tillomed is administered orally, with or without food, as directed by the prescribing physician. The tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious adverse events, although rare, include severe skin reactions such as Stevens‑Johnson syndrome, significant mood changes including depression or suicidal thoughts, hematologic abnormalities like leukopenia, and allergic reactions that may progress to anaphylaxis. Patients should seek immediate medical attention if any of these symptoms occur.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric disorders, or those taking interacting medications that markedly reduce its plasma concentration.